HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Mina Yamamoto Selected Research
Mina Yamamoto Research Topics
Disease
4
Inflammation (Inflammations)
03/2019 - 01/2008
4
Atopic Dermatitis (Atopic Eczema)
01/2017 - 06/2007
4
Dermatitis
01/2017 - 06/2007
2
Psoriasis (Pustulosis Palmaris et Plantaris)
03/2019 - 02/2014
2
Otitis
01/2017 - 01/2008
1
Autoimmune Diseases (Autoimmune Disease)
03/2019
1
Candidiasis (Moniliasis)
12/2008
Drug/Important Bio-Agent (IBA)
3
Antigens
IBA
01/2017 - 01/2008
3
Ointments (Pastes)
IBA
10/2009 - 06/2007
2
Interleukin-17 (Interleukin 17)
IBA
03/2019 - 02/2014
2
Interleukins
IBA
03/2019 - 02/2014
2
Immunoglobulin E (IgE)
IBA
10/2009 - 06/2007
1
Retinoic Acid Receptors (Retinoic Acid Receptor)
IBA
03/2019
1
S18-000003
IBA
03/2019
1
Dinitrofluorobenzene
IBA
01/2017
1
1,4-dihydropyridine (dihydropyridine)
IBA
01/2017
1
cyclohexanecarboxylic acid
IBA
01/2017
1
S-777469
IBA
01/2017
1
Cannabinoids
IBA
01/2017
1
CB2 Cannabinoid Receptor
IBA
01/2017
1
Imiquimod (Aldara)
FDA Link
Generic
02/2014
1
Cytokines
IBA
02/2014
1
Interferon-alpha (Interferon Alfa)
IBA
02/2014
1
Interleukin-22 (IL-22)
IBA
02/2014
1
Ligands
IBA
02/2014
1
Toll-Like Receptors (Toll-Like Receptor)
IBA
02/2014
1
Leflunomide (Arava)
FDA Link
Generic
12/2008
1
(2- fluoro- 2',5'- dimethyl- 4'- (6- (3- methyl- 2- butenyloxy)pyridin- 3- yl) biphenyl-4-yl)-(3-methyl-2-butenyl)amine
IBA
12/2008
1
Picryl Chloride (Trinitrochlorobenzene)
IBA
01/2008
1
Phospholipases (Phospholipase)
IBA
01/2008
1
N- (- 4- (N- (biphenyl- 2- ylmethyl)- N- 2- methylpropylamino)- 1- (2- (2,4- difluorobenzoyl)benzoyl)pyrrolidin- 2- yl)methyl- 3- (4- (2,4- dioxothiazolidin- 5- ylidenemethyl) phenyl)acrylamide
IBA
01/2008
1
diphenyl (biphenyl)
IBA
01/2008
1
Interferon-gamma (Interferon, gamma)
IBA
06/2007
1
Adrenal Cortex Hormones (Corticosteroids)
IBA
06/2007
1
Interleukin-13
IBA
06/2007
1
Interleukin-5 (Interleukin 5)
IBA
06/2007
1
Allergens
IBA
06/2007
1
Tacrolimus (Prograf)
FDA Link
Generic
06/2007
Therapy/Procedure
1
Topical Administration
03/2019